Regen BioPharma (RGBP) Loans and Notes Receivables (2016 - 2022)
Historic Loans and Notes Receivables for Regen BioPharma (RGBP) over the last 5 years, with Q2 2022 value amounting to $5396.0.
- Regen BioPharma's Loans and Notes Receivables changed 0.0% to $5396.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $5396.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $5396.0 for FY2021, which is N/A changed from last year.
- Per Regen BioPharma's latest filing, its Loans and Notes Receivables stood at $5396.0 for Q2 2022, which was down 0.0% from $5396.0 recorded in Q1 2022.
- Regen BioPharma's 5-year Loans and Notes Receivables high stood at $5396.0 for Q2 2021, and its period low was $4551.0 during Q1 2018.
- Moreover, its 3-year median value for Loans and Notes Receivables was $5396.0 (2021), whereas its average is $5079.1.
- Data for Regen BioPharma's Loans and Notes Receivables shows a peak YoY increase of 0.0% (in 2018) and a maximum YoY decrease of 0.0% (in 2018) over the last 5 years.
- Quarter analysis of 3 years shows Regen BioPharma's Loans and Notes Receivables stood at $4551.0 in 2018, then rose by 18.57% to $5396.0 in 2021, then changed by 0.0% to $5396.0 in 2022.
- Its Loans and Notes Receivables was $5396.0 in Q2 2022, compared to $5396.0 in Q1 2022 and $5396.0 in Q4 2021.